- Home
- NNAVW vs GNLX Comparison
NNAVW vs GNLX Comparison
Compare NNAVW & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNAVW
- GNLX
- Stock Information
- Founded
- NNAVW 2007
- GNLX 2001
- Country
- NNAVW United States
- GNLX United States
- Employees
- NNAVW 96
- GNLX N/A
- Industry
- NNAVW Industrial Machinery/Components
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- NNAVW Industrials
- GNLX Health Care
- Exchange
- NNAVW Nasdaq
- GNLX Nasdaq
- Market Cap
- NNAVW N/A
- GNLX 96.6M
- IPO Year
- NNAVW N/A
- GNLX 2023
- Fundamental
- Price
- NNAVW $6.35
- GNLX $2.87
- Analyst Decision
- NNAVW
- GNLX Strong Buy
- Analyst Count
- NNAVW 0
- GNLX 4
- Target Price
- NNAVW N/A
- GNLX $17.75
- AVG Volume (30 Days)
- NNAVW 53.1K
- GNLX 151.1K
- Earning Date
- NNAVW 03-12-2025
- GNLX 08-13-2025
- Dividend Yield
- NNAVW N/A
- GNLX N/A
- EPS Growth
- NNAVW N/A
- GNLX N/A
- EPS
- NNAVW N/A
- GNLX N/A
- Revenue
- NNAVW $4,963,000.00
- GNLX N/A
- Revenue This Year
- NNAVW N/A
- GNLX N/A
- Revenue Next Year
- NNAVW N/A
- GNLX N/A
- P/E Ratio
- NNAVW N/A
- GNLX N/A
- Revenue Growth
- NNAVW 43.44
- GNLX N/A
- 52 Week Low
- NNAVW $4.47
- GNLX $1.60
- 52 Week High
- NNAVW $4.70
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- NNAVW N/A
- GNLX 52.48
- Support Level
- NNAVW N/A
- GNLX $2.75
- Resistance Level
- NNAVW N/A
- GNLX $3.17
- Average True Range (ATR)
- NNAVW 0.00
- GNLX 0.25
- MACD
- NNAVW 0.00
- GNLX 0.01
- Stochastic Oscillator
- NNAVW 0.00
- GNLX 44.74
About NNAVW NextNav Inc. Warrant
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.